PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group. With this strategic alliance, PLG, a global provider of regulatory and compliance services for the life sciences industry, reinforces its ability to tackle the Italian market on its core services and positions itself as a global leader in the industry. With more than two hundred and fifty employees, Pharma D&S Group is PLG's largest build-up to date.

PARIS and FLORENCE, Italy, June 6, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality management services for the Pharmaceutical, Biotech and Medtech industries, announces its intention to merge with Pharma D&S Group, the leading Italian player in the industry.

Founded in 2001 by Riccardo Ballerini, Pharma D&S Group grew in 2003 with the arrival of Lino Fabrizi as partner. It strengthened its service offering on Regulatory Affairs, Product Quality and Process Compliance, Pharmacovigilance and Clinical Operations activities. In 2004, the Group launched Pharma Education Center (PEC), a training provider for the Life Sciences sector. In 2005, the two partners were joined by Marco Conti who founded C&P Engineering a consulting entity providing high-quality services specialized in pharmaceutical process engineering, qualification and computer systems validation.

This new deal is a key step in PLG's growth, making up for a company of more than one thousand and two hundred employees with a strong and expert presence across the globe. For Xavier Duburcq, CEO of PLG, "Pharma D&S Group is a renowned leader on the Italian market with a long standing emphasis on quality and expertise. The synergies between our two companies are high, and our values and corporate cultures have a lot in common, thanks to the entrepreneurial spirit at both PLG and Pharma D&S Group."

"Twenty years after launching Pharma D&S Group, I am convinced that joining PLG is the future of our organization", says Riccardo Ballerini, Founder and Chairman of Pharma D&S. "The merger with PLG provides our clients and the life sciences industry with access to a global footprint and a more robust combined set of capabilities across all of our key value areas".